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ABSTRACT RbdA is a positive regulator of biofilm dispersal of Pseudomonas aerugi-
nosa. Its cytoplasmic region (cRbdA) comprises an N-terminal Per-ARNT-Sim (PAS)
domain followed by a diguanylate cyclase (GGDEF) domain and an EAL domain,
whose phosphodiesterase activity is allosterically stimulated by GTP binding to the
GGDEF domain. We report crystal structures of cRbdA and of two binary complexes:
one with GTP/Mg2 bound to the GGDEF active site and one with the EAL domain
bound to the c-di-GMP substrate. These structures unveil a 2-fold symmetric dimer
stabilized by a closely packed N-terminal PAS domain and a noncanonical EAL dimer.
The autoinhibitory switch is formed by an -helix (S-helix) immediately N-terminal to
the GGDEF domain that interacts with the EAL dimerization helix (6-E) of the other
EAL monomer and maintains the protein in a locked conformation. We propose
that local conformational changes in cRbdA upon GTP binding lead to a structure
with the PAS domain and S-helix shifted away from the GGDEF-EAL domains, as
suggested by small-angle X-ray scattering (SAXS) experiments. Domain reorientation
should be facilitated by the presence of an -helical lever (H-helix) that tethers the
GGDEF and EAL regions, allowing the EAL domain to rearrange into an active di-
meric conformation.
IMPORTANCE Biofilm formation by bacterial pathogens increases resistance to anti-
biotics. RbdA positively regulates biofilm dispersal of Pseudomonas aeruginosa. The
crystal structures of the cytoplasmic region of the RbdA protein presented here re-
veal that two evolutionarily conserved helices play an important role in regulating
the activity of RbdA, with implications for other GGDEF-EAL dual domains that are
abundant in the proteomes of several bacterial pathogens. Thus, this work may as-
sist in the development of small molecules that promote bacterial biofilm dispersal.
KEYWORDS cyclic di-GMP, PAS domain, GGDEF-EAL domain, Pseudomonas
aeruginosa, biofilm, crystal structure, phosphodiesterase, diguanylate cyclase,
allosteric control, GGDEF domain, allosteric
Cytoplasmic second messengers provide an internal representation of externalconditions encountered by bacterial cells. Original cues are amplified into an
intracellular signal capable of eliciting various biochemical and metabolic changes.
Bis-(3=,5=)-cyclic dimeric GMP (c-di-GMP) (1) is a second messenger involved in the
regulation of several bacterial processes, such as motility, virulence, and biofilm for-
mation (2, 3). The cellular concentration of c-di-GMP is controlled by enzymatic
domains with opposing activities: GGDEF domain proteins with diguanylate cyclase
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(DGC) activity and EAL or HD-GYP domain proteins, which are c-di-GMP-specific phos-
phodiesterases (PDEs) (4–6). Synthesis of c-di-GMP from two GTP molecules results
from the cooperative action of two GGDEF domains arranged in a 2-fold symmetric
quaternary conformation such that their active (A) (half) sites face each other, and each
half active site binds one GTP molecule. A second c-di-GMP binding site, termed the I
site and containing an RXXD motif immediately preceding the GGDEF catalytic motif,
functions in product inhibition of the DGC activity via a feedback inhibition mechanism
(4, 7, 8). Conversely, hydrolysis of the c-di-GMP phosphodiester bond is catalyzed by
EAL and HD-GYP domains, yielding 5=-pGpG or GMP. Active EAL domains characterized
structurally so far also form 2-fold symmetric dimers through a conserved protein
interface that involves two alpha helices (5 and 6) and a regulatory loop from each
monomer (loop 6; also named the 5-5 loop) (9–12).
Many proteins containing either a GGDEF or EAL domain have been identified in
pathogenic and nonpathogenic bacteria, where they regulate c-di-GMP levels and
biofilm formation (13–19). Intriguingly, in several instances, these two enzymatic
modules can be fused in the order GGDEF-EAL via a linker region. We refer to these as
“GGDEF-EAL dual domains.” Several proteins containing a dual domain have either DGC
activity, PDE activity, or no enzymatic activity at all, because one or the other enzymatic
module has degenerate and hence inactive catalytic motifs (16, 20–24). For example,
the FimX protein of Pseudomonas aeruginosa has inactive EAL and GGDEF domains and
merely functions as a c-di-GMP cellular sensor (20). However, an increasing number of
proteins with dual domains with both enzymatic activities and that can conditionally
switch between DGC and PDE activities have been identified, including diguanylate
cyclase 1 (dgc-1) from Gluconacetobacter xylinus (21, 25) and the GGDEF-EAL proteins
BphG1 from Rhodobacter sphaeroides (26), ScrC from Vibrio parahaemolyticus (27),
MSDGC1 fromMycobacterium smegmatis (28), Rv1354c fromMycobacterium tuberculosis
(28), and CC3396 from Caulobacter crescentus (16). Given the genomic abundance of
dual-domain proteins and the involvement of these proteins in signaling pathways of
opportunistic bacterial pathogens, a better understanding of how their enzymatic
activities are regulated, leading to a certain level of cellular c-di-GMP and a defined
phenotype in terms of biofilm formation or dispersal, is crucial. Higher cellular c-di-GMP
concentrations are associated with a sessile lifestyle and biofilm formation, while lower
concentrations of the messenger correlate with motility and a planktonic lifestyle. For
P. aeruginosa strain PAO1, 16 proteins containing a GGDEF-EAL dual domain have
been identified (29). Most proteins containing either a GGDEF or EAL domain, as well
as dual-domain proteins, have various regulatory and sensory domains located at their
N termini. These sensor domains modulate activities in response to external stimuli (5,
17, 30), such as light or small ligands, including O2, NO, CO, or quorum-sensing
molecules (reviewed in reference 3).
Pioneering studies were conducted on the MorA protein from P. aeruginosa (31, 32)
and the LapD protein from Pseudomonas fluorescens (33). MorA is a membrane-bound
regulator of flagellar development and biofilm formation (31) that comprises two
functional DGC and PDE enzymatic domains. A crystal structure of the GGDEF-EAL dual
domain of MorA revealed a two-lobe structure maintained by canonical dimeric inter-
actions between the EAL domains, but with no interactions between the GGDEF
domains, with their A sites facing away from each other, corresponding to an inactive
DGC conformation (32). Interestingly, the linker region connecting the GGDEF domain
to the EAL domain, which comprises 19 amino acids, folds into an -helix that was
christened H-helix, to emphasize its likelihood of functioning as a hinge region between
the two enzymatic domains (32). LapD is a c-di-GMP sensor with a modular architecture
encompassing a HAMP inside-out relay module and a GGDEF domain followed by an
EAL domain, with the latter two being catalytically inactive due to the presence of
degenerate sequences at their respective active sites (33). The c-di-GMP binding site lies
in the EAL domain. In the absence of c-di-GMP, LapD is maintained in an off state by
a helix (“signaling” helix, or S-helix) immediately N-terminal to the GGDEF domain that
interacts with helix 6 of the EAL domain, restricting dinucleotide access to the EAL
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active site. c-di-GMP was proposed to release this autoinhibitory interaction and to lead
to the formation of an EAL dimeric structure (33).
To gain further insight into how the enzymatic activity of dual-domain proteins in
which both modules are potentially active is regulated, we chose to study the RbdA
protein (PA0861) of P. aeruginosa, a medically important multidrug-resistant pathogen.
The DipA (PA5017) (34) and RbdA (35) proteins have been shown to play important
roles in regulating dispersion of P. aeruginosa. The RbdA protein was demonstrated to
regulate the transition from a sessile to a motile lifestyle, possibly upon detection of
hypoxic conditions, by hydrolyzing c-di-GMP (35). Moreover, the PDE activity of RbdA
is allosterically stimulated when GTP binds to its GGDEF domain (35). Here we report
the crystal structure of the cytoplasmic region of RbdA (cRbdA) in its free form at a
resolution of 2.28 Å. This structure reveals the presence of a signaling helix (S-helix) that
maintains the protein in an autoinhibited state in a manner reminiscent of LapD (33).
We also report two binary complexes obtained by a brief soak of native crystals, namely,
complexes of cRbdA with GTP/Mg2 bound to the A site of the GGDEF domain, at
2.80-Å resolution, and of the c-di-GMP substrate bound to the EAL active site, at 3.31-Å
resolution. Since the two binary complexes could be obtained only via a brief soak of
cRbdA native crystals, not by cocrystallization of a preformed complex, the present
crystallographic analysis precluded the observation of any large conformational
changes that might be induced by GTP binding. Thus, we also studied the conforma-
tion of cRbdA in solution by using small-angle X-ray scattering (SAXS) and found
evidence of large structural changes of cRbdA following GTP binding. As in the MorA
protein (32), an -helix between the GGDEF and EAL domains (H-helix) is likely to
function as a hinge around which these two enzymatic domains can pivot. Together
with pioneering work by other groups (32, 33), the present structures enlighten the
regulation of c-di-GMP metabolism by bacterial proteins containing a dual domain and
provide information for the design of small molecules with the aim of modulating the
activity of these proteins. They illustrate the recycling of key functional structural
elements to control the activity of dual domain-containing proteins.
RESULTS AND DISCUSSION
The EAL motif of RbdA is essential for downregulating biofilm formation.
Higher levels of the second messenger c-di-GMP are associated with a sessile lifestyle,
while lower levels of c-di-GMP, provoked by its breakdown by PDEs, is associated with
biofilm dispersion and a planktonic bacterial lifestyle. In order to assess the role of the
PDE domain of RbdA in promoting biofilm dispersal, we mutated the chromosomal
copy of the rbdA gene to create the amino acid mutations E585A, L586A, and L587A in
the PAO1 strain of P. aeruginosa (Fig. 1A) and found a 3-fold increase in biofilm
formation for the corresponding triple mutant strain (Fig. 1B and C). The wrinkled
colony morphology of the RbdA triple mutant strain is in agreement with the role of
RbdA as a negative regulator of exopolysaccharide production proposed earlier (35).
This result, which is also consistent with prior phenotypic analyses of PA14 and PAO1
transposon mutants (29, 35) in which the complete rbdA gene was inactivated, suggests
that c-di-GMP breakdown by the EAL domain of RbdA is directly responsible for
downregulating biofilm formation. However, we cannot rule out the possibility that the
triple mutant is less stable than the wild-type (WT) RbdA protein and that the observed
phenotype results from loss of the entire protein, not only from the “EAL” PDE
enzymatic motif. Moreover, comparison over 20 h of the growth curves of P. aeruginosa
PAO1 and bacteria containing the mutated chromosomal copy did not reveal signifi-
cant changes (Fig. 1D).
Allosteric activation of PDE activity of cRbdA by addition of GMPPNP. We also
examined the allosteric activation of the PDE activity of cRbdA by addition of guanosine
5=---imido triphosphate (GMPPNP), an isosteric analogue of GTP. We used GMPPNP
instead of GTP to rule out the possibility that changes in the maximum velocity (Vmax)
were due to an increased concentration of c-di-GMP substrate produced by the intrinsic
DGC activity of cRbdA (see below). We found that GMPPNP is not converted into
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c-di-GMP by the GGDEF domain of cRbdA (see Fig. S1A in the supplemental material).
Using GMPPNP concentrations ranging from 5 to 500 M, we observed a gradual
increase in Vmax of up to 10.5-fold at higher GMPPNP concentrations (Fig. 1E; Fig. S1B).
This demonstrates that GMPPNP is an allosteric activator of the PDE activity of cRbdA
(Fig. 1E). Moreover, this allosteric enhancement of PDE activity can be attributed to
GMPPNP binding to the A site in the GGDEF region of cRbdA, because no enhancement
was observed when an A-site mutant of cRbdA (which can no longer bind to either
GMPPNP or GTP) was used (Fig. S1C).
Diguanylate cyclase activity of cRbdA. Using a high-pressure liquid chromatog-
raphy (HPLC)-based enzymatic assay, An et al. (35) reported that incubation of RbdA
with GTP alone led to the formation of pGpG, suggesting that RbdA potentially has
DGC activity. However, they noticed that c-di-GMP was rapidly degraded into pGpG by
the PDE activity of this dual enzyme. In the present study, in order to eliminate product
breakdown by the PDE activity of the wild-type RbdA EAL domain, we first used a
cRbdA mutant devoid of PDE activity (Fig. 1F, “PDE mutant”) that shows DGC activity
with a Vmax value of 22 M/min, a Km value of 0.84 M, and a kcat value of 26 min1.
Next, to also exclude possible feedback inhibition due to c-di-GMP product binding to
the I site of the GGDEF domain, we used a double mutant (Fig. 1F, “PDE  I site double
mutant”) in which both the EAL site and the I site were inactivated, leading to a slight
increase in the catalytic activity (Vmax value of 33 M/min, Km value of 3.3 M, and kcat
value of 33 min1). A mutation in the A site completely abrogated DGC activity,
demonstrating that cRbdA was responsible for the observed cyclase activity (and not a
contaminant DGC that could have copurified during protein overexpression). Taken
together, these data show that cRbdA has intrinsic GTP-stimulated PDE activity as well
as DGC activity conferred by its GGDEF domain.
The cRbdA protein forms a stable dimer. The RbdA protein contains two hydro-
phobic regions that anchor the protein to the P. aeruginosa inner membrane followed
by a cytoplasmic region that comprises a Per-ARNT-Sim (PAS) domain followed by a
GGDEF-EAL dual domain (Fig. 2A). Both the GGDEF and ELL catalytic amino acid motifs
are present in the protein sequence, accounting for the observation that RbdA can be
active as both a DGC and a PDE. The N-terminal domain of RbdA, which was omitted
FIG 1 Activity of the RbdA protein. (A) Bacterial colony morphologies and biofilm phenotypes of P. aeruginosa PAO1 and the rbdAE585A,L586A,L587A
chromosomal mutant. (B) Visualization of biofilm formation on polystyrene tubes. (C) Quantitative comparison of biofilm formation levels. The
data shown are means of triplicate values. Standard deviations are shown by error bars (*, P  0.05; two-tailed t test). (D) Comparative growth
curves of P. aeruginosa PAO1 and the rbdAE585A,L586A,L587A chromosomal mutant (RbdA mutant). (E) Allosteric activation of PDE enzymatic activity
of the cRbdA protein at 25°C in the presence of increasing concentrations of GMPPNP (ranging from 5 to 500 M). (F) DGC enzymatic activity
of RbdA. The PDE mutant bears the 585-ELL-587 ¡ ALL single mutation, the PDE  I site double mutant has both 585-ELL-587 ¡ ALL and
444-REGD-447¡ AEGD mutations, and the A site mutant (453-GGDEF-457¡ GGAAF) is the negative control. Reaction conditions are described
in Materials and Methods.
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FIG 2 Structure of the RbdA protein. (A) Domain organization of RbdA along its primary structure. Amino acid catalytic motifs and key
structural features are indicated. (B) cRbdA monomer with each domain colored and labeled. The N and C termini are labeled. The PAS domain
is colored green, the GGDEF domain cyan, the EAL domain red, and connecting segments crucial for protein dynamics (S-helix and H-helix)
light blue and yellow, respectively. (C) cRbdA dimer. The position of the single dyad that runs through the crystallographic dimer is indicated.
The region from positions 1 to 232 (not included in the cRbdA construct), leading to the periplasmic membrane, is represented schematically
with dashed lines. (D) Magnified view of interactions between the S-helix and the dimerization helix 6-E= from the EAL= domain. (E) The cRbdA
dimer is shown from a perpendicular direction, using the same color code.
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from the protein construct used for this study, is composed of 230 residues with low
sequence identity to known protein structures. Two predicted transmembrane helical
segments, at residues 16 to 36 (TM1) and 204 to 225 (TM2), surround a putative
periplasmic sensor domain of hitherto unknown specificity and structure. The cRbdA
fragment that was crystallized comprises the complete tripartite PAS, GGDEF, and EAL
cytoplasmic domains of RbdA (Fig. 2B). The crystal asymmetric unit contains one cRbdA
monomer (Fig. 2B), and a closely packed cRbdA dimer is generated through a crystal-
lographic dyad, giving rise to a bilobe molecule with overall dimensions of 80 Å by 88
Å by 83 Å (Fig. 2C and E). Upon dimer formation, a total solvent-accessible surface area
of 3,844 Å2 becomes buried at the monomer-monomer interface (Fig. 2C and D). A
breakdown of buried surface areas for each of the three domains of the tripartite
protein is given in Table S1. This large intermolecular interface is consistent with the
observation that cRbdA forms stable dimers in solution at all tested concentrations,
using both gel filtration chromatography and multiangle light scattering (MALS) (Fig.
S2). A similar conclusion was reached using SAXS (see below). An assignment of the
secondary structure elements of the cRbdA amino acid sequence, derived from the
present crystallographic study, is displayed in Fig. 3A (PAS region), and a structure-
based alignment with other bacterial GGDEF-EAL dual domains is shown in Fig. 4.
The PAS domain (residues 232 to 360). Residues 233 to 240, which are linked to
TM2 in the full-length protein, are disordered in the absence of the membrane
anchoring regions that were not included in the cRbdA protein construct. The core
structure of the PAS domain (Fig. 3) is composed of a six-stranded antiparallel -sheet
(with a flexible -strand at the edge of the -sheet and residues 301 to 306 being
disordered) augmented by short -helices. This topological arrangement (Fig. 3A and
B) leads to the formation of a barrel-shaped module that houses a hydrophobic pocket
in the interior of the PAS domain. A large number of aliphatic side chains, such as
Leu290, Ile296, Leu308, Ile309, Ile312, Ile317, and Leu355, form a cavity that can bind
small organic ligands (Fig. 3C). An automated database search for homologous three-
dimensional (3D) structures returned the PAS domain from NRII, a protein involved in
nitrogen regulation in Vibrio parahaemolyticus (PDB code 3B33), and PAS domains from
sensor histidine kinases (PDB codes 3OLO and 5FQ1), with the highest Z-scores being
8.0. Note that these structures are devoid of heme, which is in line with the absence
FIG 3 Structure of the PAS domain of RbdA. (A) Sequence comparisons of the PAS domains of RbdA of P. aeruginosa (accession number AAG04250.1), the
two-component system sensor histidine kinase NRII of V. parahaemolyticus (accession number WP_049877818.1), the Nostoc histidine kinase NSHisKinase
(accession number WP_010994604.1), the Geobacillus thermodenitrificans histidine kinase GtHiskinase (accession number WP_029761733.1), the oxygen sensor
protein EcDosP of E. coli (accession number P76129.4), and FixL of Bradyrhizobium japonicum (accession number CAA40143.1). The histidine residue involved
in heme chelation by FixL, which is not conserved in RbdA, is indicated with an arrow. Hydrophobic residues that form a possible ligand binding site of the
PAS domain of cRbdA are indicated with stars. Secondary structure elements of the PAS domain of RbdA are displayed above the alignment. (B) Topology of
the PAS domain. -Strands are shown as purple arrows and -helices as blue tubes, with residues at the extremities of each numbered. (C) Closeup view of
the hydrophobic core housed inside the -barrel of the PAS domain from RbdA. Hydrophobic residues forming a putative ligand binding site are depicted as
white sticks and labeled.
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of a heme-coordinating histidine residue in the PAS domain sequence of RbdA (Fig. 3A).
Accordingly, reconstitution experiments failed to give strong spectroscopic evidence
for heme binding by the cRbdA protein, although weak binding of heme was observed
when only the PAS domain was expressed (Fig. S3). The core region of the PAS domain
(residues 255 to 360) is preceded by an -helix (residues 242 to 253) (Fig. 3A and B) that
is swapped with the symmetrically equivalent helix and inserts into the concave surface
of the other PAS domain monomer (Fig. 2C). Interestingly, this swapped helix contains
an exposed hydrophobic patch made by residues Ile249, Leu251, and Ile254 that forms
interactions with the symmetry-equivalent residues (via the crystallographic dyad),
leading to the formation of a short coiled-coil structure that runs in a direction roughly
perpendicular to the cytoplasmic membrane (Fig. 2C). Thus, as seen for the PAS domain
of Rhodobacter sphaeroides (PDB code 4L9E) (36), the role of the RbdA PAS domain may
merely be limited to promoting protein oligomerization via its N-terminal helical
extension. At the C-terminal side of the PAS domain, two -helical segments (residues
360 to 380) project away from the core of the PAS domain and realize the connection
with the GGDEF domain, such that the distance between the C terminus of the core PAS
domain (taken as Met360) and the N terminus of the GGDEF domain (Thr380) is about
31 Å (Fig. 2B). As detailed below, this segment, which encompasses the S-helix, plays
a key role in holding the bilobe structure in place by making contacts with the EAL
domain of the partner molecule (Fig. 2D) (the domains from the other monomer are
labeled with prime symbols [e.g., EAL=]).
The GGDEF domain and the complex with GTP/Mg2. The PDE activity of RbdA
is enhanced in the presence of 50 M GTP, leading to the complete hydrolysis of
c-di-GMP after 30 min of incubation at 37°C, while only a small amount of substrate is
hydrolyzed by RbdA in the absence of GTP (35). This observation is in line with our
kinetic observation using the cRbdA protein in the presence of multiple concentrations
FIG 4 Structure-based amino acid sequence alignment of cRbdA and homologous domains from other GGDEF-EAL domain-containing bacterial proteins.
Secondary structure elements are based on assignments for the cRbdA protein (this work). Strictly conserved residues are highlighted in red. The catalytic motifs
of the DGC domain (A site or “GGDEF” motif and I site) and the PDE domain (“ELL” motif) are highlighted in yellow boxes. Key elements of the structure are
indicated, including the H-helix (hinge-helix) and S-helix (present in RbdA and LapD but not in MorA; no structure is available for the dual domains of DipA,
NbdA, CC3396, and Tbd1265). Accession numbers are as follows: Tbd1265, WP_011311777.1; LapD, WP_011331847.1; MorA, WP_073670889.1; FimX,
WP_033999828.1; CC3396, WP_010921225.1; and NBDA, WP_048305406.1. Blue stars indicate GTP-interacting residues (GGDEF domain) and red stars c-di-GMP
binding residues (EAL domain).
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of GMPPNP (Fig. 1E) and with published data (35). To obtain a molecular basis for this
effect, we determined the structure of a binary complex between cRbdA and GTP via
a brief soak of native crystals in the presence of Mg2 (Fig. 5A and B; Table S2). A
detailed view of the atomic interactions formed between GTP and residues from the A
site of the GGDEF domain is displayed in Fig. 5B. Residue Asp455 from the GGDEF motif
and Asp412 coordinate one Mg2 ion, which neutralizes negative charges from the
FIG 5 Interaction between the GGDEF domain of cRbdA and the GTP allosteric activator of PDE activity. (A) Overall view of the cRbdA monomer, highlighting
the location of the bound GTP molecule within the GGDEF domain. (B and D) Closeup views showing the atomic interactions between GTP (sticks) and residues
of the A site of the GGDEF domain (blue) (B) and the Mg (green sphere) coordination shell (D). A difference electron density map with Fo-Fc Fourier coefficients,
with the GTP moiety omitted from the calculation, is displayed at a level of 3. (C) Conformational changes in RbdA triggered by GTP binding. An overlay of
the native (blue) and GTP-bound (white) cRbdA structures is shown. Residues near the phosphate tail of GTP, including in helix 2-G, and undergoing large
displacements between the GTP-free and bound states are shown as sticks and labeled. A list of atomic interactions between the GGDEF domain and GTP is
given in Table S2 in the supplemental material, and contacts between the EAL domain of cRbdA and c-di-GMP are shown in Table S3.
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triphosphate group of GTP (Fig. 5C and D; Fig. S4). The N-2 atom of the guanine makes
hydrogen bonds with the carbonyl oxygen of His425 and with the amide group of the
amide side chain of Asn420. Overall, the bound GTP/Mg2 closely overlaps the GTP/
Mg2 bound to the GGDEF domain of PleD (PDB code 2V0N) (8). To detect conforma-
tional changes in the RbdA protein that might be triggered by GTP binding, we
superimposed the native/Hg structure with the GTP binary complex (Fig. 5C). Following
superposition, the overall root mean square deviation (RMSD) between all main chain
atoms is 0.48 Å. Compared to the native/Hg structure, the side chains of two basic
residues, Lys525 (which makes a salt bridge with Asp412 in the native structure) and
Arg529, are repositioned and neutralize the -phosphate group of GTP. Moreover, the
N-terminal region of helix 2-G (Gln415-Phe416) undergoes a significant conformational
change (RMSD of2 Å) to accommodate the triphosphate group of GTP, with the main
chain of Gln415 displaced by a distance of 2.8 Å and its side chain by 6.3 Å. It is possible
that such local structural disturbances triggered by GTP binding propagate throughout
the RbdA dimer, leading to larger conformational changes, such as whole-domain
reorientations. However, these could not be observed using X-ray crystallography,
possibly due to structural constraints on protein flexibility imposed by the crystal
lattice. This hypothesis is consistent with the observation that longer soaks with GTP
(typically 10 min) led to crystal lattice disruption and also with SAXS data demon-
strating large conformational changes upon GTP binding, as detailed below. Binding of
GTP to the A site of the GGDEF domain is in line with the work of An et al. (35), who
observed that when the five signature motif residues GGDEF were mutated to alanine
to generate the variant GGDEF-5A, the PDE activity of the mutant was similar to that of
the WT enzyme, regardless of the presence or absence of GTP. In the present confor-
mation of the cRbdA dimer, the two A sites (or GTP binding sites) are separated by a
distance of 31 Å (Fig. 2E). In order to be active as a DGC, both GGDEF domains must
adopt a specific 2-fold symmetrical orientation such that their respective half active
sites are brought into close proximity (4, 7). We concluded that in the present
orientation, the GGDEF domains of cRbdA do not function as a DGC but solely as GTP
sensors and that GTP binding is conducive to an enhancement of PDE activity through
an interaction between GTP and the A site of the GGDEF domains that triggers a range
of conformational changes in the RbdA protein, both locally (Fig. 5C) and globally (see
below).
The EAL domain and the complex with the c-di-GMP substrate. Following
superpositioning of the structures of cRbdA bound to c-di-GMP and cRbdA, the overall
RMSD between all main chain atoms is 0.56 Å. The connection between the GGDEF and
EAL domains of cRbdA is made by an -helix (residues 537 to 562) spanning a distance
of 37 Å that we name the H-helix, to retain the nomenclature originally proposed for
the dual domain-containing protein MorA from P. aeruginosa, in which this connecting
helix is also present (32). Interestingly, a structurally equivalent helix is also located at
the N-terminal end of the EAL domain of LapD, where it is named 0-E (33). Superpo-
sitioning of the GGDEF-EAL dual domains from MorA, LapD, and RbdA shows that the
H-helix acts as a hinge region, allowing the GGDEF domain to adopt various orienta-
tions with respect to the EAL domain (Fig. 6A to C). The interdomain flexibility afforded
by the presence of the H-helix potentially leads to the formation of alternative EAL-EAL=
and GGDEF-GGDEF= dimeric assemblies while preserving the 2-fold symmetry of the
whole RbdA dimer. The EAL domain of RbdA (residues 562 to 795) is formed by a (/)8
barrel capped by a lobe that comprises C-terminal residues 553 to 562 of the H-helix
and helix 1-E, which forms part of the c-di-GMP substrate binding site. In the “closed
conformation” of the cRbdA dimer captured here, the c-di-GMP binding site faces the
A site from the GGDEF domain of the same monomer (Fig. 6A). Detailed views of the
interactions between c-di-GMP and active site residues of the EAL domain are pre-
sented in Fig. 6D and Fig. S5. Even in the absence of Ca2, which is commonly used to
inhibit PDE activity, an intact c-di-GMP molecule is bound to the active site, which is in
line with the observed weak intrinsic PDE activity of RbdA and with the brief soaking
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time used to obtain this complex. Overall, the orientation of c-di-GMP in the EAL active
site is closely superimposable on that of the substrate in the isolated PDE of MorA
bound to c-di-GMP (PDB code 4RNH) (32). Catalytic residues are located at the
C-terminal end of the barrel, including residues that form the metal ion binding site and
the evolutionarily conserved residues from loop 6 (D709FCAGMSS716). Although the
complex was crystallized in the presence of Mg2, no residual electron density indic-
ative of a divalent metal is visible in the EAL active site. Systematic studies of dimeriza-
tion by EAL domain-containing proteins showed that EAL domains form dimers
through a conserved dimerization interface involving two -helices (5-E and 6-E) and
loop 6 (Fig. 4) (2, 9–12). This mode of interaction is also found in the dimeric EAL
proteins TBD1265 from Thiobacillus denitrificans (9), YahA (37), YkuI from Bacillus subtilis
(11), RocR (12, 38, 39), and BlrP1 from Klebsiella pneumoniae (10), with the same
structural elements involved in stabilizing the EAL-EAL interface (40). In the present
quaternary conformation of the cRbdA dimer, the PAS= and GGDEF= domains occupy
the space of the EAL dimeric partner (labeled EAL=), and disruption of the interatomic
contacts established between the S-helix and helix 6-E= and a large rotation of the
GGDEF domain with respect to the EAL domain are required to allow the formation of
FIG 6 Comparison of three dual domain-containing proteins, highlighting the range of relative orientations permitted by pivoting around the hinge helix. The
EAL domain has the same orientation in panels A to C. (A) View of the GGDEF-EAL dual domain from RbdA, highlighting the hinge helix (magenta) that connects
the EAL domain to the GGDEF domain and the S-helix (magenta) that contacts helix 6-E= in trans from the partner EAL= domain (shaded). The c-di-GMP moiety
bound to the EAL domain is shown as green sticks (dashed circle). A salt bridge between Asp518 (GGDEF domain) and Arg609 (EAL domain) is also represented.
(B) View of LapD (PDB code 3PJT). The S-helix contacts helix 6-E in cis from the same EAL monomer, resulting in an autoinhibited state. (C) View of MorA (PDB
code 4LYK), which also possesses the H-helix, but with a flexible N-terminal segment (no visible S-helix in the available crystal structure). The Lys1076-Glu1213
salt bridge between the GGDEF and EAL domains is shown as sticks. (D) Difference electron density map with Fo-Fc Fourier coefficients, with c-di-GMP (sticks)
omitted from the calculation. The inset shows a magnified view of the interactions established between the EAL domain of RbdA and c-di-GMP. Hydrogen
bonds are shown as black dashed lines and van der Waals and stacking interactions as purple dashed lines.
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a canonical and catalytically active EAL dimer. Moreover, an inward movement of loop
6 is also needed to avoid steric hindrance at the EAL-EAL canonical interface.
Conformations adopted by cRbdA in solution. As detailed above, the crystal
structure of cRbdA reveals a dimer locked in an autoinhibited conformation via an
extensive set of interactions established in trans between the S-helix and the 6-E
dimerization helix of the EAL= domain (Fig. 2C), which is otherwise involved in EAL-EAL=
canonical dimer formation. In the closed conformation of the cRbdA dimer captured
here (Fig. 6A), the c-di-GMP binding site of the EAL domain and the A site of the GGDEF
domain of the same monomer face each other, largely occluded from the solvent,
thereby restricting accessibility to their substrates. The observation of an autoinhibited
conformation for cRbdA suggests that alternative dimeric structures are possible in
solution, including one conformation where the EAL domains of each monomer
assemble as a canonical dimer stabilized by isologous (symmetry-equivalent) interac-
tions between helices 5-E and 6-E and loop 6 (35). In addition, we cannot rule out
formation of a GGDEF dimer whereby both A sites would be brought into close
proximity, leading to the activation of DGC activity, as suggested by the observation
that RbdA can produce pGpG by using solely GTP as the substrate (35). We performed
SAXS measurements to identify the range of conformations that cRbdA can adopt in
solution. As shown in Fig. S6 and Table S4, cRbdA exists as a dimer in solution at all
tested protein concentrations, and no aggregation is observed in the Guinier plot. The
experimental radius of gyration (Rg) of cRbdA at 2.5 mg/ml is 45.4  1.4 Å, and the
maximum particle size (Dmax) is 151  10 Å (Fig. 7A and B). Based on the Porod and
excluded volumes and the volume of correlation, cRbdA adopts a dimeric state in
solution at the concentrations used (Table S4). Rigid body modeling of cRbdA was
performed by allowing flexibility for the regions connecting the individual domains and
keeping the PAS dimer intact. The resulting molecular model is extended, has good
agreement with the experimental scattering curve (2  0.9) (Fig. 7F), and fits nicely to
the solution shape, with a normalized spatial distance (NSD) of 2.4 (Fig. 7D). Next, we
performed an analysis of the conformations adopted by cRbdA in the presence of
various ligands (Fig. 7A; Fig. S7). As shown in Fig. 7A and B, the experimental Rg value
(46.2  1.3 Å) of cRbdA remained unaffected by addition of c-di-GMP, within the error
range, albeit with a different profile in the distance distribution plot (Fig. 7B). In
contrast, addition of GTP led to a significant reduction of about 7 Å, with an Rg value
of 38.5  0.8 Å and a Dmax value of 125  10 Å (Table S4), demonstrating that cRbdA
converts to a more compact conformation in the presence of GTP. Interestingly, the
presence of GTP and c-di-GMP (40.1  0.8 Å) or GMP and c-di-GMP (40.7  0.8 Å) also
caused cRbdA to change to a more compact structure (Fig. 7A to C). An analysis of the
flexibility of cRbdA alone or bound to GTP, GMP, or c-di-GMP by use of a normalized
Kratky plot (Fig. 7C) demonstrated that cRbdA is intrinsically flexible, while cRbdA
bound to either GTP, GTP and c-di-GMP, or GMP and c-di-GMP is less flexible. In
comparison, cRbdA bound only to c-di-GMP showed more flexibility and appeared to
be more extended, with a fit to the cRbdA extended conformation returning a 2 value
of 2.5. Analysis of mixtures of various conformational states indicated that cRbdA in the
presence of c-di-GMP contains a 25% extended conformation (Rg  46.2 Å) and a 75%
compact conformation (Rg  38.5 Å) (Fig. 7F), with a good agreement (2  0.8) with
the experimental scattering curve. Low-resolution molecular shapes for cRbdA deter-
mined ab initio from the experimental data revealed a bilobe structure (Fig. 7D). The
volume of the larger lobe can house the GGDEF-EAL dimer, while the smaller lobe is
likely to correspond to the PAS domains. Remarkably, addition of GTP led to a change
of the molecular shape suggestive of a reorganization of the dual domain that
comprises the GGDEF-EAL dimer, while the PAS domains were shifted away from the
dual domain (Fig. 7E). Given the relatively low resolution of the shapes determined by
SAXS, however, several possible dimeric arrangements of the GGDEF-EAL dual domain,
such as the one revealed by the cRbdA crystal structure or one where the two EAL
monomers assemble as a canonical dimer, can be fit into the large lobe, with compa-
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FIG 7 Solution X-ray scattering studies of cRbdA with ligands. (A) Experimental scattering patterns (Œ) and calculated scattering profiles (lines)
of crystal structure dimers of cRbdA alone (black) and in complex with GTP and c-di-GMP (cdG), GMP and cdG, GTP, and cdG. (Inset) Guinier plots
show linearity at all concentrations used, indicating no aggregation. The scattering profiles were offset, for clarity, by applying arbitrary scale
factors. (B) Overlapping of pair-distance distribution function P(r) of cRbdA and its ligand complexes. cRbdA complexes with GTP and cdG, GMP
and cdG, and GTP have similar profiles; however, cRbdA with cdG has an extended tail. (C) Normalized Kratky plot of cRbdA (black) compared
to its complexes and the compact globular lysozyme (gray), with a peak (gray dashed line) representing the theoretical peak and assuming an
(Continued on next page)
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rable discrepancies. Likewise, whether reorientation of the two GGDEF domains into an
active DGC enzyme can also occur awaits further structural studies. In this respect, we
note that the length of the H-helix is compatible with extensive domain reorientations
leading to drastically distinct quaternary arrangements (Fig. 6).
Model for allosteric activation of PDE activity of RbdA. One main conclusion of
solution studies conducted on cRbdA is that in the absence of ligand, the protein
appears to be rather flexible but becomes more compact in the presence of GTP.
Together with the observation of an apparently autoinhibited conformation in the
crystal structure, these findings suggest the following model for the allosteric activation
of the PDE activity of RbdA, which is consistent with available data (Fig. 8). In the
simplest scenario, two conformational states adopted by the protein are associated
with low and high PDE activities. The autoinhibited state is achieved via a set of
interactions established in trans between helix 6-E= and residues 361 to 365 from the
S-helix, immediately N-terminal to the GGDEF domain, which locks the EAL domains in
a noncanonical configuration. We also noted an evolutionarily conserved basic residue,
Arg369 in RbdA (Fig. 2D and 4), that also projects from the S-helix but toward the PAS=
domain, and as a result is deeply buried in the protein interior at the dimer interface
(Fig. 2D). Arg369 makes stacking interactions with the phenyl ring of Tyr366 and the
imidazole ring of His358= and one salt bridge with the carboxylic group of Glu322= of
FIG 7 Legend (Continued)
ideal Guinier region of a globular particle. The scattering pattern of cRbdA and its complexes exhibits a broad bell-shaped profile shifted toward
the right with respect to standard globular proteins, indicating the presence of motion in the protein. (D) Averaged and filtered envelope (gray)
from 20 independent ab initio reconstructions created by use of DAMMIF superimposed onto a cartoon representation of the CORAL model with
an extended conformation for cRbdA, with the PAS domain in blue, the GGDEF domain in purple, and the EAL domain in brown. The second
subunit is colored in lighter shades. The linker regions modeled between the domains are shown as green and cyan spheres for the subunits.
Front (left) and side (right) views are displayed. (E) Averaged and filtered ab initio low-resolution shape of cRbdA in the presence of GTP and
c-di-GMP (green) superimposed on the compact conformation generated from CORAL. (F) Fitting of the CORAL model (red lines) to the
experimental scattering patterns (Œ) for cRbdA alone (black) and with GTP and c-di-GMP (green). The theoretical scattering curve for the mixture
of 75% compact and 25% extended conformations of cRbdA dimers (black line) calculated using the OLIGOMER program fits the experimental
scattering pattern of cRbdA with cdG (orange), with a 2 value of 0.8.
FIG 8 Proposed allosteric mechanism regulating the PDE activity of RbdA. The left panel schematically represents the
putative autoinhibited state observed in the cRbdA crystal structure. This resting state is stabilized by interactions between
helix 6 from the EAL domain and the S=-helix immediately N-terminal to the GGDEF= domain (and also between helix 6-E=
and the S-helix in the other monomer, via the dyad). These interactions lock both EAL domains of the RbdA dimer in a
noncanonical configuration. Upon signal detection by either the putative periplasmic sensor domain (triangle) or GTP
binding to the A sites of the GGDEF domains, local conformational changes (Fig. 5D) propagate throughout the protein
and lead to the release of the autoinhibitory interactions between helix 6-E and the S=-helix. This is proposed to lead to
the rearrangement of both EAL domains into a canonical dimer capable of hydrolyzing the incoming c-di-GMP substrate
and to the observed higher PDE activity (Fig. 1D) conducive to biofilm dispersal (right panel).
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the PAS= domain (Fig. 2D). A preliminary mutagenesis study targeting Arg369 (Table S5)
suggested that an Arg369Glu mutant partly released the autoinhibitory switch, leading
to a higher PDE activity.
Following GTP binding to the A site of the GGDEF domains (Fig. 5), local confor-
mational changes as pictured in Fig. 5C for helix 2-G would propagate throughout the
protein and lead to the release of the autoinhibitory interactions between 6-E= and the
S-helix, and possibly also exposure of Arg369 to the solvent, allowing the EAL domains
to rearrange into a canonical dimer capable of hydrolyzing the incoming c-di-GMP
substrate. An alternative but not mutually exclusive model for PDE activation involves
detection of a signal by the putative periplasmic sensor domain, leading to a confor-
mational rearrangement of the bundle of TM helices and of the S helices transmitted
through the coiled-coil region N-terminal to the PAS domains. Again, the final PDE-
active state is formed by the canonical EAL dimer, as displayed schematically in Fig. 8.
Earlier studies (16) of the dual domain-containing protein CC3396 demonstrated that
allosteric activation of PDE via GTP was derived from a reduction of the Km for c-di-GMP
from 100 M in the absence of GTP to 420 nM when GTP was present, and this large
increase in affinity of the substrate is likely to derive from a better chemical comple-
mentarity afforded by structural changes induced in the c-di-GMP binding site upon
canonical dimer formation. As discussed by Jenal and colleagues (16), why would the
PDE activity be coupled to cellular levels of GTP? The cellular concentration of GTP is
likely to reflect the overall cellular nutrient level, as it is also correlated with the level
of the alarmone (p)ppGpp upon starvation of nutriments, including amino acids or
nitrogen. When the GTP abundance is low, the PDE activity of RbdA is switched off to
prevent exhaustion of the GTP pool, promoting biofilm formation. Conversely, in the
presence of a large amount of GTP, the PDE activity is switched on, leading to biofilm
dispersal. Importantly, we cannot exclude the existence of dimeric quaternary confor-
mations for RbdA other than the two depicted schematically in Fig. 8, given our
observation that a cRbdA double (I site and ELL) mutant can display DGC activity (Fig.
1F). Quaternary structures with the two GGDEF domains forming a dimer with both A
sites facing each other may in principle be conducive to DGC activity, although their
relevance is not established for RbdA, in the sense that this protein likely evolved to use
its GGDEF domain as a GTP sensor, as outlined above, rather than for c-di-GMP
synthesis. If this assumption is correct, quaternary conformations with A sites facing
each other should represent only a minor population in the ensemble of possible
protein structures present in equilibrium in solution. One interesting possibility is that
RbdA also functions as a rheostat by integrating signals both from its putative periplas-
mic sensor domain and from the detection of intracellular GTP levels via its GGDEF
domain, leading to a contextually optimal PDE activity. In this respect, we note an
interesting overall mechanistic similarity between RbdA and the dimeric LapD sensor,
which has a periplasmic output domain capable of binding a ligand (the LapG cysteine
protease) and a cytoplasmic PDE domain able to sense c-di-GMP (33). For both RbdA
and LapD, the autoinhibitory switch is made of an “S-helix” that locks the protein in a
resting state via its interaction with the EAL domain, restricting accessibility to the EAL
active site and preventing active dimer formation.
A large number of dual domain signaling systems fused to various sensor domains
have now been identified (41–44). RbdA represents a useful model for studying how
signals become integrated in the context of one protein with potential dual enzymatic
activity. An important conclusion of the present work is that the apparent conservation
of several regulatory structural elements, such as signaling (or S-helix) and lever (or
H-helix) elements, across various bacterial proteins (Fig. 4 and 5) suggests that similar
molecular mechanisms are at play in controlling c-di-GMP metabolism by GGDEF-EAL
domain-containing dual proteins. Given the abundance of dual protein genes in the
genomes of several major human pathogens, this observation offers attractive per-
spectives for better understanding the role of c-di-GMP in controlling biofilm formation
and also for the design of molecules to interfere with this process.
Liu et al. Journal of Bacteriology
February 2018 Volume 200 Issue 3 e00515-17 jb.asm.org 14
 o
n
 M
arch 8, 2018 by UNIVERSITY O
F TECH SYDNEY
http://jb.asm.org/
D
ow
nloaded from
 
MATERIALS AND METHODS
Bacterial strains, growth conditions, and biofilm formation and quantification. Unless otherwise
indicated, bacteria were grown at 37°C in lysogeny broth (LB). The wild-type P. aeruginosa PAO1 strain
was obtained from the University of Washington. The rbdAE585A,L586A,L587A (rbdAAAA) mutant was created
based on the PAO1 strain. Briefly, a DNA fragment of 1,518 bp containing an rbdAE585A,L586A,L587A gene
construct was amplified by overlap extension PCR with P. aeruginosa PAO1 genomic DNA as the
template. The PCR product was cloned into the vector pK18GT at BamHI and HindIII sites to generate the
suicide plasmid pK18Gm-rbdAAAA. The suicide plasmid was transformed into Escherichia coli DH5 for
subsequent conjugation with PAO1 by triparental mating with the helper plasmid pRK600. The transcon-
jugants were selected on Pseudomonas isolation agar (PIA) medium plates (Difco) containing
gentamicin (60 g/ml). Colonies resulting from the first crossover events were streaked onto LB agar
plates supplemented with 10% (wt/vol) sucrose, and sucrose-sensitive colonies were selected as positive
colonies. Colonies that contained the correct mutations were identified by sequencing of the DNA
fragment. The colony morphology assay was performed as follows. An overnight culture was diluted to
an optical density at 600 nm (OD600) of 0.025 in T-broth (10 g/liter tryptone). Five microliters of diluted
culture was spotted on a Congo red plate (10 g/liter tryptone, 40 g/ml Congo red, 20 g/ml Coomassie
brilliant blue, 1% agar). The plates were incubated at room temperature for 3 days before photography
was performed. For biofilm visualization, overnight cultures were diluted to an OD600 of 0.002 with fresh
LB, and 500 l of diluted culture was transferred to a 5-ml polystyrene tube and incubated at 37°C with
shaking at 180 rpm for 24 h. Cultures were removed carefully. Biofilms were washed with water, stained
with 1 ml 0.1% (wt/vol) crystal violet in each tube for 15 min, and then rinsed with water several times.
The tubes were air dried for several hours before photography was performed. The biofilm assay was
performed by diluting the bacterial culture at exponential phase to an OD600 of 0.05 with fresh LB broth.
Subsequently, 100 l of diluted culture was transferred to each well of a 96-well microplate and
incubated at 37°C for 24 h. The biofilms were washed with water, stained with 125 l 0.1% (wt/vol) crystal
violet in each well for 15 min, and then rinsed with water. The plates were air dried for several hours.
Biofilms were dissolved with 125 l 30% (vol/vol) acetic acid in each well for 15 min, and the absorbance
at 550 nm was measured. Each experiment was repeated at least three times in triplicate.
Growth curves. OD measurements of bacterial cultures were performed in an Infinite 200 Pro
microplate reader (Tecan). Absorbance was measured at a wavelength of 600 nm and a temperature of
37°C, and the mean for four readings was taken. Bacteria grown to an OD600 of 0.2 to 0.3 were diluted
in fresh LB medium to an OD600 of 0.01. The culture was transferred to a Costar flat-bottomed 96-well
plate with a lid and a volume of 200 l per well. Plates were incubated for 67 cycles (about 22 h in total),
and readings were taken after 1,000 s of shaking for 180 rpm and 30 s of static incubation in each cycle.
Cloning, expression, and purification of cRbdA. A codon-optimized gene encoding the full-length
(818 residues) wild-type protein RbdA (PA0861) from P. aeruginosa for expression in E. coli was purchased
from Genscript. A fragment encoding residues 233 to 800 of the protein, which includes its entire PAS,
GGDEF, and EAL domains (Fig. 2A), was subsequently cloned into the pNIC-CH2 expression vector
(Novagen) with the coding sequence for a C-terminal hexahistidine tag (construct vc012 of the NTU
Protein Production Platform; here referred to as cRbdA, with a calculated molecular mass of 64,439 Da).
Successful recombinants were transformed into E. coli Rosetta(DE3) competent cells. Expression of the
cRbdA protein was induced with 0.15 mM isopropyl--D-thiogalactopyranoside (IPTG; GoldBio) at 16°C
for 16 to 20 h, following the addition of 4% (vol/vol) ethanol to the culture to enhance protein solubility.
Cells were harvested by centrifugation and resuspended in buffer A [20 mM HEPES at pH 7.5, 500 mM
NaCl, 10% (vol/vol) glycerol, and 0.5 mM tris(2-carboxyethyl)phosphine (TCEP)] supplemented with
protease inhibitor cocktail set III, EDTA free (Calbiochem, Merck), and Benzonase nuclease (Sigma-Aldrich)
prior to lysis using an LM20 Microfluidizer instrument (Microfluidics). The lysate was clarified by
centrifugation at 48,000	 g for 40 min, and the supernatant was filtered through a 0.22-m syringe filter
before being loaded onto 2 ml of Ni-nitrilotriacetic acid (Ni-NTA) resin (Roche) preequilibrated with buffer
A supplemented with 2 mM MgCl2 (buffer B). After washing with buffer B supplemented with 20 mM
imidazole, bound proteins were eluted with buffer B containing 100 mM imidazole. The eluate was
subjected to anion exchange using a HiTrap Q HP 5-ml column (GE Healthcare) equilibrated in buffer B,
and cRbdA was eluted in a NaCl gradient ranging from 0 to 1 M NaCl. Finally, pooled fractions containing
the cRbdA protein were concentrated and subjected to size exclusion chromatography (SEC) with a
Superdex 200 16/600 column (GE Healthcare) preequilibrated in buffer B, with a 0.5-ml/min flow rate.
Fractions containing cRbdA (including the C-terminal histidine tag), as confirmed by SDS-PAGE, were
pooled and concentrated using Vivaspin concentrators (Sartorius). Concentrated proteins at 8 mg/ml
were flash frozen in liquid N2 and stored at 80°C until use.
Cloning, expression, and purification of cRbdA mutants. Synthetic genes were purchased from
Bio Basic Asia Pacific (Singapore). We expressed the following four cRbdA mutants by using the method
outlined above: (i) an A-site DGC-inactive mutant containing a 453-GGDEF-457 ¡ GGAAF mutation, (ii)
a PDE-inactive mutant containing a 585-ELL-587 ¡ ALL mutation, (iii) an I-site mutant containing a
444-REGD-447 ¡ AEGD mutation, and (iv) a double mutant with an inactive PDE and I site, with both
585-ELL-587 ¡ ALL and 444-REGD-447 ¡ AEGD mutations in order to measure unbiased DGC activity.
PDE activity measurement. We measured the time course of pGpG formation without the allosteric
activator GTP or in the presence of the isosteric guanosine 5=-(--imido)triphosphate (GMPPNP)
molecule (a nonhydrolyzable GTP analogue). We found that GMPPNP is not converted to c-di-GMP by the
DGC activity of cRbdA (see Fig. S1 in the supplemental material), thus ensuring that changes in Vmax are
not due to an increased concentration of the c-di-GMP substrate produced by intrinsic cRbdA DGC
activity. We used GMPPNP at concentrations of 0, 5, 10, 25, 50, 100, 250, or 500 M, cRbdA at 1 M, and
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c-di-GMP at 100 M, and reactions were performed in duplicate. The hydrolysis of c-di-GMP was
quenched by adding 0.1 M CaCl2 (to inhibit the EAL domain activity), and the amount of pGpG formed
was resolved in a 4.6-mm by 250-mm by 5-m C18 column (Agilent) in 20 mM triethylammonium
bicarbonate, 9% (vol/vol) methanol, mounted on a Prominence HPLC (Shimadzu) and analyzed using
Prism software (GraphPad, San Diego, CA).
DGC activity measurement. We employed an HPLC-based assay analogous to that outlined above
to analyze c-di-GMP formation by cRbdA. In order to eliminate potential feedback inhibition by c-di-GMP
binding to the I site of the enzyme and also to prevent hydrolysis of c-di-GMP by the PDE activity of
cRbdA, we used a cRbdA double mutant having both 585-ELL-587 ¡ ALL and 444-REGD-447 ¡ AEGD
mutations to measure DGC activity. The A-site mutant of cRbdA (453-GGDEF-457 ¡ GGAAF) was used
as a negative control, and all reactions were done in triplicate.
Crystallization of cRbdA and crystallographic data collection. The homogeneity and oligomeric
state of cRbdA were assessed by multiangle light scattering in combination with size exclusion chro-
matography (SEC-MALS; Wyatt Technology) (Fig. S2). Crystallization conditions were screened by sitting-
drop vapor diffusion in 96-well plates, using a mosquito LCP liquid handler (TTP Labtech). Rhombohedral
crystals of the cRbdA proteins were obtained at 20°C by using 1 l of protein at a concentration of 8
mg/ml and 1 l of reservoir solution containing 0.1 M morpholineethanesulfonic acid (MES)-imidazole at pH
6.5 (obtained by mixing 30.6 ml of 1 MMES at pH 2.7 with 19.4 ml of 1 M imidazole at pH 9.9, as implemented
in Morpheus “buffer system 1” [Molecular Dimensions]), 0.1 M carboxylic acid, 10% (wt/vol) polyethylene
glycol 4000 (PEG 4000), and 20% (vol/vol) glycerol. Initial data sets to about 2.8- to 3.0-Å resolution could be
collected with native crystals. Following a 5-min soak in reservoir solution containing 1 mM HgCl2, diffraction
data were extended to 2.28-Å resolution (Table 1). The cRbdA-GTP and cRbdA–ci-di-GMP binary complexes
were obtained by transferring native cRbdA crystals to a freshly prepared reservoir solution, supple-
mented with either 1 mM GTP and 2 mM MgCl2 or 1 mM c-di-GMP and 2 mM MgCl2, and soaking them
for 4 to 5 min (Table 1). Longer soaking led to a severe deterioration of the diffraction quality of the
crystals and to crystal breakage. Data were collected at the Australian Synchrotron (beamlines MXI and
MXII; Clayton, Melbourne, Australia) and the Swiss Light Source (SLS) (beamline PXIII; Paul Scherrer
Institute, Switzerland). Diffraction intensities were integrated with XDS (45) and scaled using SCALA (46)
from the CCP4 suite (47). Data collection statistics are summarized in Table 1.
Structure determination. The asymmetric unit of the crystal comprises a single cRbdA monomer.
The structure was determined using molecular replacement as implemented in the CCP4 package (47),
leading to a partial model comprising only the GGDEF and EAL domains. Clear residual electron density
was observed for large parts of the PAS domain as well as for segments linking the PAS domain to the
GGDEF domain and the GGDEF domain to the EAL domain. The program BUCANEER (48) was then used
to extend this partial model. Several rounds of manual model building were then performed using the
program COOT (49), interspersed with refinement with the program BUSTER (50), leading to a model
comprising residues 241 to 300 and 309 to 797 of the protein (Table 2). An anomalous Fourier map
calculated with phases from the partial model revealed a major Hg site bound to Cys521 of the GGDEF
domain (at a level of 6.85 ) and two minor Hg sites, bound to Cys436 and Cys423, giving further
confidence in the correctness of the structure determination. Interface areas and solvation energies were
calculated by the protein interface, surface, and assembly service PISA (51). Figures were generated with
TABLE 1 Data collection statistics
Parameter
Value for data setc
Native, with HgCl2 cRbdA-GTP/Mg2 cRbdA–c-di-GMP
Soaking time (min)/concn (mM) 5/1 4/1 5/1
Beamline (synchrotron) PXIII (SLS) MXI (Australian Synchrotron) PXIII (SLS)
Wavelength (Å) 1.0000 0.9537 1.0000
Resolution (Å) 70.20–2.28 (2.40–2.28) 47.90–2.80 (2.95–2.80) 48.70–3.31 (3.49–3.31)
Space group H32 H32 H32
Cell parameters a, b, c (Å) 134.71, 134.71, 210.45 134.73, 134.73, 209.95 134.88, 134.88, 211.22
// (°) 90/90/120 90/90/120 90/90/120
No. of measured reflections 202,176 (29,411) 193,115 (28,079) 112,687 (16,413)
No. of unique reflections 33,717 (4,851) 18,306 (2,610) 11,308 (1,624)
Redundancy 6.0 (6.1) 10.5 (10.8) 10.0 (10.1)
I/ 10.7 (1.7) 9.5 (2.5) 11.3 (4.0)
Completeness (%) 100.0 (100.0) 100.0 (100.0) 99.9 (99.6)
Rmergea (%) 12.4 (106.0) 27.6 (107.0) 19.1 (61.8)
Rpimb (%) 5.4 (45.4) 8.9 (34.3) 6.8 (20.4)
CC(1/2)d (%) 99.7 (51.7) 0.988 (0.705) 99.1 (87.8)
aRmerge  |Ij  I|/Ij, where Ij is the intensity of an individual reflection and I is the average intensity of that reflection.
bRpim
hkl 1n	1j1n |Ihkl,j	Ihkl|
hkl j Ihkl,j .
cValues in parentheses indicate values in the highest-resolution shell.
dCC(1/2), Pearson correlation coefficient.
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the program PyMOL (Schrodinger Scientific). Structure-based alignment of cRbdA against homologs was
generated with ESPript (52). Interface areas buried during dimer formation are listed in Table S1.
Small-angle X-ray scattering. X-ray scattering data from wild-type cRbdA and its complexes with
GTP, GMP, and c-di-GMP were collected on a Bruker Nanostar SAXS instrument equipped with a Metal-Jet
X-ray source (Excillum, Germany) and a Våntec 2000 detector system. The scattering patterns were
measured using a sample detector distance of 0.67 m and a wavelength (
) of 1.3414 Å, covering the
range of momentum transfer of 0.016  q  0.4 Å1 [q  4 sin()/
, where 2 is the scattering angle].
To monitor for radiation damage, six 5-min exposures were collected for each protein sample, and no
radiation effect was observed. cRbdA was measured at concentrations of 1.6, 2.5, and 3.6 mg/ml, while
the ligand complexes were measured at 2.5 mg/ml. The data were normalized to the intensity of the
transmitted beam, and the scattering of the buffer was subtracted. The difference curves were scaled for
concentration, and the data processing steps were performed using the program package PRIMUS from
the ATSAS package, version 2.7.1 (53). The forward scattering value I(0) and the radius of gyration (Rg)
were computed using the Guinier approximation. The pair distribution functions were calculated by
GNOM (54) and also provided the maximum particle size (Dmax), and the low-resolution shape of
wild-type cRbdA was determined ab initio by use of DAMMIF (55). Qualitative particle motion was
inferred by plotting the scattering patterns in the normalized Kratky plot [(qRg)2(I(q)/I(0)) versus qRg] (56).
The theoretical scattering curves from atomic structures were generated and evaluated against exper-
imental scattering curves by use of CRYSOL (57). Utilizing the intensities from each component, the
volume fraction of each component could be determined by use of OLIGOMER (49). Rigid body modeling
was performed using CORAL (58), by docking the individual domains of the high-resolution structures
against the experimental data. The oligomeric state of the protein was confirmed from the molecular
mass calculation, based on I(0), Porod volume (Vp), excluded volume (Vex), and volume of correlation (Vc)
(59).
Accession number(s). The structures from this study have been deposited in the Protein Data Bank
under accession numbers 5XGB, 5XGD, and 5XGE.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/JB
.00515-17.
SUPPLEMENTAL FILE 1, PDF file, 1.4 MB.
TABLE 2 Refinement statistics
Parameter
Value for data set
Native, with HgCl2 cRbdA-GTP/Mg2 cRbdA–c-di-GMP
Data range (Å) 70.20–2.28 (2.35–2.28) 27.55–2.80 (2.97–2.80) 48.70–3.31 (3.63–3.31)
No. of reflections used for refinement 33,717 (2,884) 18,292 (2,774) 11,285 (2,663)
No. of nonhydrogen protein atoms 4,318 4,294 4,295
Rworka (%) 0.193 (0.224) 0.172 (0.195) 0.174 (0.167)
Rfreeb (%) 0.229 (0.276) 0.255 (0.259) 0.259 (0.272)
CC Fo-Fc 0.938 0.927 0.922
RMSD
Bond length (Å) 0.010 0.010 0.010
Bond angle (°) 1.11 1.19 1.21
BWilson/Boverall (Å2) 44.3/52.0 55.4/44.7 93.4/57.0
Estimated coordinate error (Å)c 0.19 0.36 0.53
Mean B factor (Å2)
Protein 38.8 45.0 58.1
Ligands
c-di-GMP 78.5 (46)
GTP 47.2 (32)
Mg2 18.9 (1)
Water molecules (no.) 38.9 (303) 40.0 (315) 37.4 (162)
No. (%) of residues in Ramachandran plot
Most favored 531 (97.1) 518 (95.2) 509 (93.6)
Allowed 15 (2.7) 22 (4.1) 33 (6.1)
Disallowed 1 (0.2) 4 (0.7) 2 (0.4)
PDB code 5XGB 5XGD 5XGE
aRwork  ||Fo|  |Fc||/|Fc|, where Fo denotes the observed structure factor amplitude and Fc denotes the structure factor amplitude calculated from the model.
bRfree was calculated in the same way as Rwork, but with 5% of randomly chosen reflections omitted from the refinement.
cEstimated coordinate error is based on (dispersion precision indicator [DPI]) Rfree.
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